Association of beta-catenin and CD44 in the development of renal cell carcinoma.
Akash AgrawalChhanda DattaChinmay Kumar PandaDilip Kumar PalPublished in: Urologia (2020)
Both cd44 and beta-catenin activation was noted in patients with clear cell carcinoma, more in advanced tumors. Both can be promising targets for treatment in clear cell RCCs.